|
⚲
|
| Keyboard |
| Lundbeckfond Invest A/S
✚
|
|
|---|---|
| CIK # | 0001591046 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001591046] | |
| 4 | [0001591046] | |
| SC 13D | [0001591046] | |
| SC 13G | [0001591046] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Lexeo Therapeutics Inc | |
| Lundbeckfond Invest A/S | |
| IO Biotech Inc | |
| Enliven Therapeutics Inc | |
| Trevi Therapeutics Inc | |
| scPharmaceuticals Inc | |
| Spero Therapeutics Inc | |
| Celladon Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Lexeo Therapeutics Inc LXEO
Common Stock
|
2023-11-07 | Buy | 227,272 | $11.00 | 2,499,992 |
|
Lexeo Therapeutics Inc LXEO
Series A convertible preferred stock · derivative
|
2023-11-07 | Conversion | 13,999,999 | ||
|
Lexeo Therapeutics Inc LXEO
Series B convertible preferred stock · derivative
|
2023-11-07 | Conversion | 2,615,533 | ||
|
Lexeo Therapeutics Inc LXEO
Common Stock
|
2023-11-07 | Conversion | 1,321,474 | ||
|
Lexeo Therapeutics Inc LXEO
Common Stock
|
2023-11-07 | Conversion | 287,213 | ||
|
IO Biotech Inc IOBT
Common Stock
|
2023-08-09 | Grant | 7,901,234 | $1.90 | 15,012,345 |
|
IO Biotech Inc IOBT
Warrants (Right to Buy) · derivative
|
2023-08-09 | Grant | 7,901,234 | $0.13 | 1,027,160 |
|
IO Biotech Inc IOBT
Series B Preferred Stock · derivative
|
2021-11-09 | Conversion | 219,595 | $0.00 | |
|
IO Biotech Inc IOBT
Common Stock
|
2021-11-09 | Conversion | 2,014,161 | ||
|
IO Biotech Inc IOBT
Common Stock
|
2021-11-09 | Conversion | 1,892,434 | ||
|
IO Biotech Inc IOBT
Common Stock
|
2021-11-09 | Buy | 2,142,857 | $14.00 | 29,999,998 |
|
IO Biotech Inc IOBT
Series C Preferred Stock · derivative
|
2021-11-09 | Conversion | 150,534 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Series Seed Preferred Stock · derivative
|
2020-03-16 | Conversion | 478,749 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Common Stock
|
2020-03-16 | Buy | 187,500 | $16.00 | 3,000,000 |
|
Enliven Therapeutics Inc IMRA
Common Stock
|
2020-03-16 | Conversion | 1,245,222 | ||
|
Enliven Therapeutics Inc IMRA
Series A Preferred Stock · derivative
|
2020-03-16 | Conversion | 5,470,492 | $0.00 | |
|
Enliven Therapeutics Inc IMRA
Series B Preferred Stock · derivative
|
2020-03-16 | Conversion | 1,894,444 | $0.00 | |
|
Trevi Therapeutics Inc TRVI
Common Stock
|
2019-05-09 | Buy | 375,000 | $10.00 | 3,750,000 |
|
Trevi Therapeutics Inc TRVI
Series C Preferred Stock · derivative
|
2019-05-09 | Conversion | 6,849,315 | $0.00 | |
|
Trevi Therapeutics Inc TRVI
Common Stock
|
2019-05-09 | Conversion | 776,544 | ||
| showing 20 of 32 most recent transactions | |||||